To confirm that tumor neutrophils indeed exhibited a pronounced glycolytic signature as well as enhanced HIF-1α expression, we assessed the protein expression of glucose transporter 1 (GLUT1; a glycolytic marker) and HIF-1α by immunofluorescence. The gene discussed is HIF1A; the disease is neoplasm.